The purpose of the project is to clone and characterize novel chemokine receptors in activated lymphocytes. Chemokines are members of a family of more than thirty human cytokines whose best described activities are as chemotactic factors for leukocytes and that act through receptors that are members of the G protein coupled receptor superfamily. Chemokines and their receptors are increasingly recognized as important in the trafficking of lymphocytes in immune and inflammatory responses as well as other aspects of lymphocyte physiology. Because lymphocytes are important in responses to infectious agents as well as in autoimmune diseases, inflammatory disorders, and transplant rejection, secreted factors and receptors that effect lymphocyte recruitment to tissue are potential targets for therapeutic interventions. Characterization of chemokine receptors on lymphocytes is of added medical relevance given the recent discoveries that chemokine receptors function as obligate co-receptors for HIV-1 entry, so that understanding these receptors may lead to novel therapies for preventing and treating HIV infection. Work during the last year has focused on the receptor CXCR6 (STRL33), an HIV/SIV co-receptor that was discovered in this laboratory and whose ligand is CXCL16. By altering amino acids in one of the receptor?s intracellular domains (intracellular loop 2), we have found that functional conformations of the receptor depend on co-operative effects of conserved residues within this domain and that mutations in this domain produce receptors whose activity is cell-type dependent, presumably due to selective use of cell-type specific signaling pathways.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000749-07
Application #
6986359
Study Section
(LCI)
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
2004
Total Cost
Indirect Cost
Name
Niaid Extramural Activities
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Chung, Jo L; Sun, Jian; Sidney, John et al. (2010) IMMUNOCAT-a data management system for epitope mapping studies. J Biomed Biotechnol 2010:856842
Jacobson, Orit; Weiss, Ido D; Szajek, Lawrence et al. (2009) 64Cu-AMD3100--a novel imaging agent for targeting chemokine receptor CXCR4. Bioorg Med Chem 17:1486-93
Darash-Yahana, Merav; Gillespie, John W; Hewitt, Stephen M et al. (2009) The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers. PLoS One 4:e6695
Singh, Satya P; Zhang, Hongwei H; Foley, John F et al. (2008) Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J Immunol 180:214-21
Lupo, P; Chang, Y C; Kelsall, B L et al. (2008) The presence of capsule in Cryptococcus neoformans influences the gene expression profile in dendritic cells during interaction with the fungus. Infect Immun 76:1581-9
Menke, Julia; Zeller, Geraldine C; Kikawada, Eriya et al. (2008) CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease. J Am Soc Nephrol 19:1177-89
Rose, Jeremy J; Foley, John F; Murphy, Philip M et al. (2004) On the mechanism and significance of ligand-induced internalization of human neutrophil chemokine receptors CXCR1 and CXCR2. J Biol Chem 279:24372-86
Venkatesan, Sundararajan; Rose, Jeremy J; Lodge, Robert et al. (2003) Distinct mechanisms of agonist-induced endocytosis for human chemokine receptors CCR5 and CXCR4. Mol Biol Cell 14:3305-24
Farber, Joshua M; Berger, Edward A (2002) HIV's response to a CCR5 inhibitor: I'd rather tighten than switch! Proc Natl Acad Sci U S A 99:1749-51
Liao, Fang; Shirakawa, Aiko-Konno; Foley, John F et al. (2002) Human B cells become highly responsive to macrophage-inflammatory protein-3 alpha/CC chemokine ligand-20 after cellular activation without changes in CCR6 expression or ligand binding. J Immunol 168:4871-80

Showing the most recent 10 out of 12 publications